The Canadian Bioceutical Corporation Announces Name Change to MPX Bioceutical Corporation

Visit the MPX Bioceutical Corporation Investor Dashboard and stay up to date with data-driven, fact based due diligence for active traders and investors.

  • Election of Board of Directors
  • Appoint Deloitte LLP as Auditor
  • Appointment of Officers
  • Issuance of Stock Options
  • Entering into Executive Services Agreement with Canadian Capital, LLC

TORONTO, Nov. 02, 2017 (GLOBE NEWSWIRE) — MPX Bioceutical Corporation (formerly The Canadian Bioceutical Corporation) (the “Company” or “MPX”) (CSE:BCC) (OTC:MPXEF) today

... read more at: